These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

288 related items for PubMed ID: 825763

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. In vitro bactericidal action of cefoperazone, cefoxitin, cefuroxime, cefazolin and cephaloridine.
    Piantieri G, Cafarelli A, Magliulo E.
    G Batteriol Virol Immunol; 1981; 74(1-6):15-25. PubMed ID: 6458524
    [No Abstract] [Full Text] [Related]

  • 6. [Microbiological evaluation of cefoxitin, a new beta-lactamase resistant cephamycin antibiotic, compared to cephalothin, cephaloridine and cefazolin].
    Schassan HH, Bentfeld G.
    Fortschr Med; 1978 Aug 10; 96(30):1510-7. PubMed ID: 669547
    [Abstract] [Full Text] [Related]

  • 7. Antimicrobial evaluation of cefoxitin: a new semisynthetic cephamycin. Comparative studies with cefazolin and cefalotin.
    Une T, Mitsuhashi S.
    Arzneimittelforschung; 1977 Aug 10; 27(1):89-93. PubMed ID: 576821
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A comparison of the in vitro activity of a new cephalosporin, cefuroxime, and cephalothin against 810 clinical isolates.
    Skar AG, Midtvedt T, Dahl O.
    NIPH Ann; 1979 Dec 10; 2(2):31-40. PubMed ID: 398460
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Comparison of four recently introduced cephalosporins with respect to probability of resistance in multiresistant strains of Escherichia coli, Proteus mirabilis and Klebsiella spec. (author's transl)].
    Loch R, Schröter G.
    Zentralbl Bakteriol Orig A; 1979 Dec 10; 245(3):312-6. PubMed ID: 44785
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Evaluation of in vitro antimicrobial activity of cefazolin alone and in combination with cefmetazole or flomoxef using agar dilution method and disk diffusion method].
    Matsuo K, Uete T.
    Jpn J Antibiot; 1992 Oct 10; 45(10):1253-66. PubMed ID: 1479676
    [Abstract] [Full Text] [Related]

  • 16. In-vitro anti-microbial susceptibility of clinical isolates of pathogenic bacteria to ten antibiotics including phosphomycin.
    Eke PI, Rotimi VO.
    Afr J Med Med Sci; 1987 Mar 10; 16(1):1-8. PubMed ID: 3037870
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Microbiological activity of cefazedone as compared to cefazolin and cephalothin.
    Knothe H.
    Arzneimittelforschung; 1979 Mar 10; 29(2a):378-81. PubMed ID: 39575
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Comparison of in vitro activity of first, second and third generation cephem antibiotics against various pathogens isolated from clinical materials in 1983].
    Matsuo K, Tsuzaki Y, Furukawa S, Uete T.
    Jpn J Antibiot; 1984 Jun 10; 37(6):1040-57. PubMed ID: 6387213
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.